Raphael Pharmaceutical (RAPH) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Raphael Pharmaceutical Inc.  (OTC: RAPH)

Raphael Pharmaceutical Profitability Comparisons

Select each Category to receive further Information




RAPH Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) - 43.02 % 33.27 % 46.05 %
Gross Margin (Q2 TTM) - 49.58 % 34.27 % 46.3 %
Gross Profit Margin 5 Yr. Avg. - 5.26 % 42.17 % 26.86 %
EBITDA Margin (Q2 MRQ) - -3.62 % 16.22 % 20.6 %
EBITDA Margin (Q2 TTM) - -22.21 % 14.72 % 19.1 %
EBITDA Margin 5 Yr. Avg. - --42.92 % 12.45 % 10.9 %
Operating Margin (Q2 MRQ) - -19.96 % 12.61 % 16.03 %
Operating Margin (Q2 TTM) - -34.86 % 11.19 % 16.33 %
Operating Margin 5 Yr. Avg. - --44.88 % 12.71 % 8.17 %
Pre-Tax Profit Margin (Q2 MRQ) - -15.3 % 11.66 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) - -35.47 % 10.37 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - - 5.15 % 8.22 %
Net Margin (Q2 MRQ) - -23.05 % 9.49 % 11.41 %
Net Margin (Q2 TTM) - -41.08 % 7.84 % 10.75 %
Net Margin 5 Yr. Avg. - - 0.98 % 6.23 %